Press Releases

CHICAGO--(BUSINESS WIRE)-- Exicure, Inc. (Nasdaq: XCUR), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. In September 2022, the Company announced a significant reduction in force, suspension of preclinical activities and halting of all research and development, and that the Company was exploring strategic alternatives to maximize stockholder value.

Third... (continue reading...)

NEW YORK--(BUSINESS WIRE)-- KBRA assigns preliminary ratings to five classes of notes issued by Verdant Receivables 2024-1 LLC (Verdant 2024-1), an equipment ABS transaction.

Verdant Commercial Capital, LLC (Verdant or the Company) is a small- and medium-ticket independent equipment finance company founded in July 2017 and headquartered in Cincinnati, Ohio. Verdant employs a vendor model generating originations through relationships with original equipment... (continue reading...)

REDWOOD CITY, CA / ACCESSWIRE / May 16, 2024 / Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of $11 million or approximately 80% of its existing debt with entities affiliated with CRG Partners III L.P. ("CRG") into a shares of a new series of convertible preferred... (continue reading...)

Profitable Growth Continues with 1Q24 Adjusted EBITDA up 126% YoY and Revenues Increasing 9% YoY

BRITISH VIRGIN ISLANDS--(BUSINESS WIRE)-- Despegar.com, Corp. (NYSE: DESP) (“Despegar” or the “Company”), Latin America’s leading travel technology company, today announced unaudited financial results for the three-months ended March 31, 2024 (“first quarter 2024” or “1Q24”). Financial results are expressed in U.S. dollars and are presented in... (continue reading...)

Kelowna, British Columbia--(Newsfile Corp. - May 16, 2024) - F3 Uranium Corp. (TSXV: FUU) (OTCQB: FUUFF) ("F3 Uranium" or the "Company") announces that it has revised the pricing of its previously announced private placement for gross proceeds of C$9,059,531.83 (the "Underwritten Offering"). Under the revised Underwritten Offering, the Company will issue 6,820,784 federal flow-through units of the Company (the "FFT Units") at a price of C$0.5355 per FFT Unit (the "FFT... (continue reading...)